Researchers uncovered why cells with double the normal amount of DNA often evade normal cell death mechanisms, establishing a link to both cancer development and aging processes. These DNA-doubled cells, known as polyploid cells, arise through errors in cell division and accumulate in tissues over time.
Normal cells possess programmed death pathways that eliminate damaged or abnormal copies before they proliferate uncontrollably. The study identified specific molecular changes that allow polyploid cells to bypass those safeguards, permitting them to survive and potentially contribute to tumor formation or tissue dysfunction.
Cancer researchers have long observed polyploid cells in aggressive tumors, but the precise mechanisms enabling their persistence were not fully understood. The new findings provide a framework for investigating whether targeting those survival pathways could improve cancer therapy or slow age-related tissue degeneration.
Aging tissues also accumulate polyploid cells, suggesting the discovery may have implications beyond oncology for understanding frailty and organ decline. Scientists said additional work is needed to determine whether interventions against the identified pathways would be safe in living organisms.
Cell cycle regulation research intersects with oncology drug development as pharmaceutical companies seek targets that restore normal death pathways in malignant polyploid populations. Aging research teams examine whether senolytic strategies that eliminate damaged polyploid cells can improve tissue function in organs where such cells accumulate with advancing age.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://www.sciencedaily.com/news/top/health/